13S148: COVID-19: Strategies to Protect Pediatric Patients

Sunday, November 13, 2022

3:00 PM – 4:00 PM Eastern Time

Location: Terrace Ballroom I

CE: 1

All of the relevant financial relationships listed for faculty have been mitigated.

Moderator(s)

KD

Kevin Downes, MD

University of Pennsylvania/CHOP
Philadelphia, PA, United States

Disclosure(s): Merck/MSD: Grant/Research Support (Terminated)
Dawn Wahezi, MD, MS, RhMSUS

Children's Hospital at Montefiore
New Rochelle, NY, United States

Disclosure(s): No financial relationships to disclose

The COVID-19 pandemic has affected our populations broadly, but we would like to focus on the most recent mechanisms to manage it, specifically by vaccines and treatments. We will provide an overview of updates in COVID-19 vaccines in the pediatric population, management of COVID-19, and how these updates affect our patients with systemic pediatric rheumatic disease.

Learning Objectives:

Discuss updates in pediatric COVID-19 vaccines and how they affect immunocompromised kids
Review how to manage acute COVID-19 in pediatric immunocompromised patients
Highlight novel therapies and management strategies in pediatric acute COVID-19

Presentations:

3:00 PM – 3:20 PM Eastern Time

Managing Acute COVID-19 in Immunocompromised Pediatric Patients
Speaker: Anna Helena Jonsson, MD, PhD – Brigham and Women's Hospital
3:20 PM – 3:40 PM Eastern Time

Updates in COVID-19 Vaccinations for Kids & How That Will Affect Immunocompromised Kids
Virtual Speaker: Peter J. Hotez, MD, PhD – Baylor College of Medicine
3:40 PM – 4:00 PM Eastern Time

Q&A